Clinical Practice Evidence of Treatment Satisfaction with Moderate and High-Efficacy Drugs in Multiple Sclerosis
The efficacy of DMT is a significant predictor of overall satisfaction. Quality of life has a minimal impact on overall satisfaction. EDSS, treatment duration and fatigue (MFIS) were not significant predictors of satisfaction outcomes. The knowledge provided by the PROs allows healthcare professionals to better understand the preferences and needs of PwMS, adjusting therapeutic strategies, improving patient experience and treatment effectiveness.
Authors
- Raquel Piñar Morales (ORCID: https://orcid.org/0000-0003-3490-4932)
- Cristina Gutiérrez (ORCID: https://orcid.org/0000-0002-6944-772X)
- María Rosana Ramirez (ORCID: https://orcid.org/0000-0001-9989-7978)
- Carina Aguilar Martín (ORCID: https://orcid.org/0000-0002-2357-5726)
- Ángel José Morales Lahoz
- Felipe Hernández (ORCID: https://orcid.org/0009-0007-1843-9002)
- Elena López Fandila
Institutions
- Universidad de Granada (ES)
- Instituto de Investigación Biosanitaria de Granada (ES)
Publication Details
- Journal
- Patient Preference and Adherence
- Published
- 2025-03-01
- DOI
- https://doi.org/10.2147/ppa.s509525
- Citations
- 2
- Primary Topic
- Multiple Sclerosis Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 2.94